ESHRE and AUA guidance both put male evaluation alongside, not after, female workup. The data says roughly half of fertility cases involve a male factor — but in standard pathways, men are tested an average of twelve months later than their partners. The gap isn't biological, it's procedural. This page exists so you can close it in one message.
If you're reading this because the diagnostic path so far has been entirely about you, you already know the answer. The data says no. The system says wait. This page is for the conversation in between.
Most public-payer pathways recommend female workup first — cycle tracking, AMH, ultrasound. Male evaluation usually only kicks in after 12 months of unsuccessful trying. That order isn't supported by current guidelines; it's a leftover from how clinics are organised.
Surveys consistently show men are less likely to seek health advice and more likely to assume "I feel fine, so it's not me." Hormonal and sperm changes are often silent until they show up in a fertility context. Feeling fine is not evidence of fine fertility.
Until recently, the male side of testing meant a clinic appointment, a paper request, and a 4–6 week wait for a result that often only included one or two markers. The Hormone Panel 01 changes that — six markers, finger-prick at home, physician-reviewed in 3–5 days for €89.
Two minutes, no account, fully anonymous. He gets a personalised risk band based on age, lifestyle, and medical history — and a clear yes/no on whether testing makes sense for him now. The hardest part is sending the link.
If you've already had the conversation: skip the quiz. The Hormone Panel 01 ships with a finger-prick kit; he takes the sample at home, drops it in the post, and gets a physician-reviewed report in 3–5 working days. €89, ISO 15189 lab.
If you'd rather start with the evidence: our /science page indexes the primary sources on male fertility decline, age effects, and the case for parallel testing. Eleven peer-reviewed studies and guidelines, in one place.
"I read that male factors drive about half of fertility cases. There's a six-marker home test for €89. Could you do it before our next clinic appointment?"
"This came up while I was researching. It's a 30-second quiz that tells you whether testing makes sense — no commitment. Want to try it?"
"Our doctor is going to ask if you've been tested. Easier to do it now and bring the result than to start that conversation cold."
Two minutes, no account, no commitment. He gets the answer he needs to decide whether to test now. You stop carrying the diagnostic path alone.
FutureKit's Hormone Panel 01 is a screening test for information, not a clinical diagnosis. For symptoms or out-of-range results, both partners should consult a licensed physician or fertility specialist. Decisions about treatment belong with that physician.